These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1036 related articles for article (PubMed ID: 10685665)

  • 1. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
    Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
    Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
    Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression.
    Finke JH; Rayman P; George R; Tannenbaum CS; Kolenko V; Uzzo R; Novick AC; Bukowski RM
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):940s-946s. PubMed ID: 11300495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
    Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
    Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early immune response and regulation of IL-2 receptor subunits.
    Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
    Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
    Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
    Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells.
    Kudo D; Rayman P; Horton C; Cathcart MK; Bukowski RM; Thornton M; Tannenbaum C; Finke JH
    Cancer Res; 2003 Apr; 63(7):1676-83. PubMed ID: 12670922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X; Davis LS; Hashimoto K; Lipsky PE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
    Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
    Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma.
    König B; Steinbach F; Janocha B; Drynda A; Stumm M; Philipp C; Allhoff EP; König W
    Anticancer Res; 1999; 19(2C):1519-24. PubMed ID: 10365136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma.
    Bukowski RM; Rayman P; Molto L; Tannenbaum CS; Olencki T; Peereboom D; Tubbs R; McLain D; Budd GT; Griffin T; Novick A; Hamilton TA; Finke J
    Clin Cancer Res; 1999 Oct; 5(10):2780-9. PubMed ID: 10537342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings.
    Feske S; Müller JM; Graf D; Kroczek RA; Dräger R; Niemeyer C; Baeuerle PA; Peter HH; Schlesier M
    Eur J Immunol; 1996 Sep; 26(9):2119-26. PubMed ID: 8814256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells.
    Uzzo RG; Rayman P; Kolenko V; Clark PE; Cathcart MK; Bloom T; Novick AC; Bukowski RM; Hamilton T; Finke JH
    J Clin Invest; 1999 Sep; 104(6):769-76. PubMed ID: 10491412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
    Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction.
    Biswas K; Richmond A; Rayman P; Biswas S; Thornton M; Sa G; Das T; Zhang R; Chahlavi A; Tannenbaum CS; Novick A; Bukowski R; Finke JH
    Cancer Res; 2006 Jul; 66(13):6816-25. PubMed ID: 16818659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
    Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
    Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
    Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
    J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
    Kolenko V; Wang Q; Riedy MC; O'Shea J; Ritz J; Cathcart MK; Rayman P; Tubbs R; Edinger M; Novick A; Bukowski R; Finke J
    J Immunol; 1997 Sep; 159(6):3057-67. PubMed ID: 9300731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.